The leading cause of age-related blindness is macular degeneration (AMD), which gradually destroys central vision—leaving people unable to read, drive or live independently. To restore vision lost to the dry form of AMD, Mark Humayun is leading a collaborative team from USC, the University of California, Santa Barbara (UCSB), the City of Hope, Caltech and Regenerative Patch Technologies. Together, they are using stem cells to generate retina-supporting cells that grow on a membrane or “patch” surgically implanted in the eye. Some patients have already recovered partial vision after receiving the implants during clinical trials.

Amyotrophic lateral scleorosis (ALS), also known as Lou Gehrig’s disease, causes progressive paralysis and often results in respiratory failure within three to five years of diagnosis. Justin Ichida’s lab used patient-derived motor neurons to screen more than 2,000 FDA-approved drugs. The screen revealed that inhibiting a protein, called the PIKFYVE kinase, improved the survival of motor neurons from patients with ALS. Ichida co-founded a startup, AcuraStem, which developed a spinal injection therapy known as an antisense oligonucleotide (ASO) to suppress PIKFYVE. The pharmaceutical company Takeda has licensed this technology and is moving it into clinical trials.

Other USC Stem Cell scientists are exploring how the body develops, maintains and repairs the brain, nerves and senses. They are using stem cells to develop regenerative therapies for conditions including Alzheimer’s disease, neurodevelopmental disorders, brain tumors and hearing loss.

Neurosensory Researchers

Neurosensory News

Illustration of a microscope, a patient and a health care provider.

SPARK at USC helps scientists move discoveries from the lab to patients

The new program gives early-stage USC and CHLA teams funding, mentoring and a practical road map for turning promising biomedical research into potential treatments. When Eun Ji Chung began at USC, she …

In the head of this 5-day-old zebrafish, one enhancer is visible in cartilage (magenta) while another is active in the tissue surrounding the skeleton (green). (Image by Kelsey Elliott/Crump Lab/USC Stem Cell)

NIH awards $3.3 million grant to study the role of gene regulation in congenital anomalies

The project will use zebrafish and other species to understand the logic and evolution of craniofacial development. A research team led by Gage Crump, PhD, at the Keck School of Medicine of …

Images of liver cells from aged rats elucidate cellular crosstalk in the liver. (Image by DeLeve Lab/USC)

Treatment revives old liver cells in lab study, may help prevent Alzheimer’s and heart disease

Keck School of Medicine of USC research in rats finds potential for treating diseases of aging via the liver and uncovers new insights about cell signaling. The liver’s job clearing harmful substances …

All Neurosensory News

Neurosensory Videos

Dr. Justin Ichida’s research focuses on how genetic and environmental factors contribute to human neurodegenerative disease. His laboratory uses cellular reprogramming and stem cell technology to build patient-specific in vitro models of neurodegenerative disease, enabling the screening of drug-like compounds in search of potential therapeutics. To learn more, visit https://ichidalab.usc.edu.
All Neurosensory Videos